HIGHFDA DRUG
HANDELNINE GLOBAL Recalls Rheumacare Capsules Due to Lead Risk
HANDELNINE GLOBAL recalled Rheumacare capsules on December 22, 2025, after discovering lead contamination. The recall affects four bottles of 30 capsules each distributed in New York. Consumers should stop using the product immediately and contact their healthcare provider.
HANDELNINE GLOBAL
CGMP Deviations: